Nuvectra Corporation Company Profile (NASDAQ:NVTR)

About Nuvectra Corporation (NASDAQ:NVTR)

Nuvectra Corporation logoNuvectra Corporation is a neurostimulation company that focuses on helping physicians to improve the lives of people with chronic neurological conditions. The Company's Algovita Spinal Cord Stimulation (SCS) System (Algovita) is the Company's commercial offering and is Conformite Europeene (CE) marked and the United States Food and Drug Administration (FDA) approved for the treatment of chronic pain of the trunk and/or limbs. Its technology platform also has capabilities under development to support other neurological indications, such as sacral nerve stimulation (SNS) and deep brain stimulation (DBS). In addition, its NeuroNexus Technologies, Inc. (NeuroNexus) subsidiary designs, manufactures and markets neural-interface technologies for the neuroscience clinical research market. Its Virtis is an application of the Company's neurostimulation technology platform and its first product for the SNS market. Its subsidiaries include Algostim, LLC (Algostim) and PelviStim LLC (PelviStim).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Bio Medical Devices
  • Sub-Industry: N/A
  • Symbol: NASDAQ:NVTR
  • CUSIP: N/A
  • Web: www.nuvectramed.com
Capitalization:
  • Market Cap: $143.66 million
  • Outstanding Shares: 10,342,000
Average Prices:
  • 50 Day Moving Avg: $9.99
  • 200 Day Moving Avg: $7.49
  • 52 Week Range: $4.63 - $15.00
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -4.36
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $15.51 million
  • Price / Sales: 9.21
  • Book Value: $7.35 per share
  • Price / Book: 1.88
Profitability:
  • EBIDTA: ($40,650,000.00)
  • Net Margins: -286.26%
  • Return on Equity: -47.33%
  • Return on Assets: -36.79%
Debt:
  • Debt-to-Equity Ratio: 0.18%
  • Current Ratio: 4.51%
  • Quick Ratio: 4.19%
Misc:
  • Average Volume: 60,984 shs.
  • Beta: 1.2
  • Short Ratio: 1.38
 

Frequently Asked Questions for Nuvectra Corporation (NASDAQ:NVTR)

What is Nuvectra Corporation's stock symbol?

Nuvectra Corporation trades on the NASDAQ under the ticker symbol "NVTR."

How were Nuvectra Corporation's earnings last quarter?

Nuvectra Corporation (NASDAQ:NVTR) posted its quarterly earnings data on Tuesday, May, 9th. The company reported ($1.27) earnings per share for the quarter, missing analysts' consensus estimates of ($1.25) by $0.02. The firm earned $5 million during the quarter, compared to analysts' expectations of $4.61 million. Nuvectra Corporation had a negative net margin of 286.26% and a negative return on equity of 47.33%. The business's quarterly revenue was up 47.1% on a year-over-year basis. During the same quarter last year, the business earned ($0.70) earnings per share. View Nuvectra Corporation's Earnings History.

Where is Nuvectra Corporation's stock going? Where will Nuvectra Corporation's stock price be in 2017?

2 brokers have issued 12 month price targets for Nuvectra Corporation's shares. Their forecasts range from $10.00 to $12.00. On average, they anticipate Nuvectra Corporation's stock price to reach $11.00 in the next year. View Analyst Ratings for Nuvectra Corporation.

Who are some of Nuvectra Corporation's key competitors?

Who owns Nuvectra Corporation stock?

Nuvectra Corporation's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Gilder Gagnon Howe & Co. LLC (8.20%), Dimensional Fund Advisors LP (6.59%), Vanguard Group Inc. (2.83%), Laurel Wealth Advisors Inc. (1.94%), Hodges Capital Management Inc. (1.86%) and Essex Investment Management Co. LLC (1.38%). Company insiders that own Nuvectra Corporation stock include David D Johnson, Joseph A Miller, Scott F Drees and Thomas Kelley Hickman. View Institutional Ownership Trends for Nuvectra Corporation.

Who sold Nuvectra Corporation stock? Who is selling Nuvectra Corporation stock?

Nuvectra Corporation's stock was sold by a variety of institutional investors in the last quarter, including Tudor Investment Corp ET AL, Goldman Sachs Group Inc., Sessa Capital IM L.P., Renaissance Technologies LLC, Dimensional Fund Advisors LP, Laurel Wealth Advisors Inc. and California Public Employees Retirement System. View Insider Buying and Selling for Nuvectra Corporation.

Who bought Nuvectra Corporation stock? Who is buying Nuvectra Corporation stock?

Nuvectra Corporation's stock was purchased by a variety of institutional investors in the last quarter, including Granite Investment Partners LLC, Gilder Gagnon Howe & Co. LLC, Essex Investment Management Co. LLC, Hodges Capital Management Inc., FNY Partners Fund LP, Vanguard Group Inc., Wells Fargo & Company MN and Stifel Financial Corp. Company insiders that have bought Nuvectra Corporation stock in the last two years include David D Johnson, Joseph A Miller and Scott F Drees. View Insider Buying and Selling for Nuvectra Corporation.

How do I buy Nuvectra Corporation stock?

Shares of Nuvectra Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Nuvectra Corporation's stock price today?

One share of Nuvectra Corporation stock can currently be purchased for approximately $13.81.


MarketBeat Community Rating for Nuvectra Corporation (NASDAQ NVTR)
Community Ranking:  3.2 out of 5 (  )
Outperform Votes:  36 (Vote Outperform)
Underperform Votes:  20 (Vote Underperform)
Total Votes:  56
MarketBeat's community ratings are surveys of what our community members think about Nuvectra Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Nuvectra Corporation (NASDAQ:NVTR) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Hold Rating, 1 Buy Rating
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $11.00 (20.35% downside)

Analysts' Ratings History for Nuvectra Corporation (NASDAQ:NVTR)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/15/2017B. RileyReiterated RatingBuy$12.00HighView Rating Details
8/13/2016Piper Jaffray CompaniesReiterated RatingNeutral$12.00 -> $10.00N/AView Rating Details
6/3/2016Sterne Agee CRTInitiated CoverageBuy$14.00N/AView Rating Details
(Data available from 6/22/2015 forward)

Earnings

Earnings History for Nuvectra Corporation (NASDAQ:NVTR)
Earnings by Quarter for Nuvectra Corporation (NASDAQ:NVTR)
Earnings History by Quarter for Nuvectra Corporation (NASDAQ NVTR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/9/2017Q1 2017($1.25)($1.27)$4.61 million$5.00 millionViewListenView Earnings Details
3/7/2017Q4 2016($0.89)($1.27)$3.97 million$4.20 millionViewListenView Earnings Details
11/9/2016Q3 2016($0.88)($0.92)$2.81 million$3.80 millionViewListenView Earnings Details
8/10/2016Q216($1.13)($0.85)$2.40 million$2.50 millionViewListenView Earnings Details
5/11/2016Q1($0.51)($0.70)$2.06 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Nuvectra Corporation (NASDAQ:NVTR)
2017 EPS Consensus Estimate: ($4.54)
2018 EPS Consensus Estimate: ($3.17)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171($1.25)($1.25)($1.25)
Q2 20171($1.24)($1.24)($1.24)
Q3 20171($1.22)($1.22)($1.22)
Q4 20171($0.83)($0.83)($0.83)
Q1 20181($0.84)($0.84)($0.84)
Q2 20181($0.86)($0.86)($0.86)
Q3 20181($0.75)($0.75)($0.75)
Q4 20181($0.72)($0.72)($0.72)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Nuvectra Corporation (NASDAQ:NVTR)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Nuvectra Corporation (NASDAQ:NVTR)
Institutional Ownership Percentage: 58.42%
Insider Trades by Quarter for Nuvectra Corporation (NASDAQ:NVTR)
Institutional Ownership by Quarter for Nuvectra Corporation (NASDAQ:NVTR)
Insider Trades by Quarter for Nuvectra Corporation (NASDAQ:NVTR)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/30/2017Scott F DreesCEOBuy7,395$10.41$76,981.95View SEC Filing  
5/25/2017Scott F DreesCEOBuy2,605$9.92$25,841.60View SEC Filing  
3/16/2017Joseph A MillerDirectorBuy25,000$6.11$152,750.00View SEC Filing  
3/14/2017Scott F DreesCEOBuy25,000$6.21$155,250.00View SEC Filing  
1/4/2017Thomas Kelley HickmanEVPSell133$5.36$712.88View SEC Filing  
5/19/2016David D JohnsonDirectorBuy30,000$14.02$420,600.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Nuvectra Corporation (NASDAQ:NVTR)
Latest Headlines for Nuvectra Corporation (NASDAQ:NVTR)
Source:
DateHeadline
finance.yahoo.com logoNuvectra Files Regulatory Submission with FDA for Algovita® MRI-Conditional Approval
finance.yahoo.com - June 21 at 8:14 PM
americanbankingnews.com logoNuvectra Corporation (NVTR) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - June 21 at 4:42 PM
americanbankingnews.com logoTheStreet Upgrades Nuvectra Corporation (NVTR) to C-
www.americanbankingnews.com - June 21 at 2:28 PM
americanbankingnews.com logo Nuvectra Corporation (NVTR) Receives Consensus Rating of "Strong Buy" from Brokerages
www.americanbankingnews.com - June 21 at 7:48 AM
americanbankingnews.com logoNuvectra Corporation (NVTR) Rating Increased to Hold at ValuEngine
www.americanbankingnews.com - June 17 at 12:32 AM
finance.yahoo.com logoETFs with exposure to Nuvectra Corp. : June 16, 2017
finance.yahoo.com - June 16 at 7:55 PM
finance.yahoo.com logoETFs with exposure to Nuvectra Corp. : June 5, 2017
finance.yahoo.com - June 5 at 7:34 PM
finance.yahoo.com logoNuvectra Corp. :NVTR-US: Earnings Analysis: Q1, 2017 By the Numbers : June 2, 2017
finance.yahoo.com - June 2 at 8:47 PM
americanbankingnews.com logoScott F. Drees Purchases 7,395 Shares of Nuvectra Corp (NVTR) Stock
www.americanbankingnews.com - June 1 at 8:32 PM
americanbankingnews.com logoNuvectra Corp (NVTR) Raised to "Hold" at Zacks Investment Research
www.americanbankingnews.com - May 30 at 8:56 PM
americanbankingnews.com logoBrokerages Anticipate Nuvectra Corp (NVTR) to Announce ($1.24) EPS
www.americanbankingnews.com - May 29 at 4:34 PM
americanbankingnews.com logoNuvectra Corp (NVTR) CEO Purchases $25,841.60 in Stock
www.americanbankingnews.com - May 26 at 4:46 PM
americanbankingnews.com logoNuvectra Corp (NVTR) Sees Large Growth in Short Interest
www.americanbankingnews.com - May 21 at 11:14 AM
americanbankingnews.com logoNuvectra Corp (NVTR) Rating Reiterated by B. Riley
www.americanbankingnews.com - May 14 at 10:14 PM
americanbankingnews.com logoZacks Investment Research Downgrades Nuvectra Corp (NVTR) to Sell
www.americanbankingnews.com - May 13 at 9:40 AM
americanbankingnews.com logoNuvectra Corp Expected to Post Q2 2017 Earnings of ($1.24) Per Share (NVTR)
www.americanbankingnews.com - May 12 at 8:50 AM
americanbankingnews.com logoNuvectra Corp (NVTR) Releases Earnings Results, Misses Estimates By $0.02 EPS
www.americanbankingnews.com - May 9 at 11:02 PM
seekingalpha.com logoNuvectra Corporation misses by $0.02, beats on revenue
seekingalpha.com - May 9 at 6:35 PM
nasdaq.com logoNuvectra™ Reports First Quarter 2017 Financial Results
www.nasdaq.com - May 9 at 6:35 PM
streetinsider.com logoNuvectra Corporation (NVTR) Misses Q1 EPS by 2c, Beat on Revenues
www.streetinsider.com - May 9 at 6:35 PM
marketbeat.com logoNuvectra reports 1Q loss
marketbeat.com - May 9 at 5:44 PM
finance.yahoo.com logoInvestor Network: Nuvectra Corp. to Host Earnings Call
finance.yahoo.com - May 9 at 11:27 AM
finance.yahoo.com logoNuvectra to Present at the 18th Annual B. Riley Co. Investor Conference
finance.yahoo.com - May 3 at 8:07 PM
finance.yahoo.com logoNuvectra to Report First Quarter 2017 Financial Results on May 9, 2017
finance.yahoo.com - April 27 at 10:08 AM
finance.yahoo.com logoETFs with exposure to Nuvectra Corp. : April 26, 2017
finance.yahoo.com - April 26 at 6:20 PM
finance.yahoo.com logoETFs with exposure to Nuvectra Corp. : April 5, 2017
finance.yahoo.com - April 7 at 11:38 AM
finance.yahoo.com logoNuvectra Announces Cowen & Company Hosted Physician Panel on Spinal Cord Stimulation on March 29, 2017
finance.yahoo.com - March 27 at 10:00 AM
americanbankingnews.com logoZacks: Analysts Set $12.00 Price Target for Nuvectra Corp (NVTR)
www.americanbankingnews.com - March 22 at 10:31 AM
americanbankingnews.com logoNuvectra Corp (NVTR) Director Acquires $152,750.00 in Stock
www.americanbankingnews.com - March 20 at 7:55 PM
finance.yahoo.com logoNUVECTRA CORP Financials
finance.yahoo.com - March 15 at 7:07 PM
biz.yahoo.com logoNUVECTRA CORP Files SEC form 10-K, Annual Report
biz.yahoo.com - March 9 at 6:46 PM
seekingalpha.com logoNuvectra Corporation (NVTR) Presents At Cowen and Company 37th Annual Health Care Conference
seekingalpha.com - March 8 at 7:42 PM
biz.yahoo.com logoQ4 2016 Nuvectra Corp Earnings Release - Before Market Open
us.rd.yahoo.com - March 7 at 11:47 PM
nasdaq.com logoNuvectra™ Reports Fourth Quarter and Full Year 2016 Financial Results
www.nasdaq.com - March 7 at 10:02 AM
seekingalpha.com logoNuvectra Corporation misses by $0.38, beats on revenue
seekingalpha.com - March 7 at 10:02 AM
biz.yahoo.com logoNUVECTRA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
biz.yahoo.com - March 7 at 10:02 AM
finance.yahoo.com logoNuvectra to Present at the 29th Annual ROTH Conference
finance.yahoo.com - March 6 at 8:04 AM
finance.yahoo.com logoNuvectra to Present at the Cowen and Company 37th Annual Health Care Conference
finance.yahoo.com - March 1 at 10:30 AM
finance.yahoo.com logoNuvectra to Report Fourth Quarter 2016 Financial Results on March 7, 2017
finance.yahoo.com - February 21 at 5:56 PM
us.rd.yahoo.com logoNuvectra Extends Timeline of Existing Credit Facility
us.rd.yahoo.com - February 14 at 10:12 PM
finance.yahoo.com logoNuvectra to Present at the Leerink Partners 6th Annual Global Healthcare Conference
finance.yahoo.com - February 6 at 9:26 AM
us.rd.yahoo.com logoNuvectra Files Regulatory Submissions for FDA and CE Mark Approvals of the Virtis™ Sacral Nerve Stimulation (SNS) System
us.rd.yahoo.com - February 1 at 8:04 PM
us.rd.yahoo.com logo10:01 am Nuvectra files regulatory submissions with the FDA and CE Mark authorities for Virtis
us.rd.yahoo.com - February 1 at 8:04 PM
biz.yahoo.com logoNUVECTRA CORP Files SEC form 8-K, Change in Directors or Principal Officers
biz.yahoo.com - January 17 at 7:18 PM
finance.yahoo.com logoNuvectra Receives Frost & Sullivan’s New Product Innovation Award for Its Algovita® SCS System
finance.yahoo.com - January 17 at 11:25 AM
finance.yahoo.com logoNuvectra Corporation Signs Direct Supply Agreement
finance.yahoo.com - December 12 at 9:57 AM
finance.yahoo.com logo8:01 am Nuvectra completes a direct supply agreement with Minnetronix; will begin purchasing the external peripheral devices for its Algovita spinal cord stimulation system directly from Minnetronix in the first half of 2017 as it transitio
finance.yahoo.com - December 12 at 9:57 AM
finance.yahoo.com logoNuvectra to Present at the 28th Annual Piper Jaffray Healthcare Conference
finance.yahoo.com - November 21 at 11:52 AM
seekingalpha.com logoNuvectra Corporation misses by $0.04, beats on revenue
seekingalpha.com - November 10 at 9:37 AM
biz.yahoo.com logoQ3 2016 Nuvectra Corp Earnings Release - After Market Close
biz.yahoo.com - November 9 at 9:03 AM

Social

Chart

Nuvectra Corporation (NVTR) Chart for Thursday, June, 22, 2017

This page was last updated on 6/22/2017 by MarketBeat.com Staff